MARKET

UTHR

UTHR

Utd Therapeut
NASDAQ

Real-time Quotes | Nasdaq Last Sale

91.32
-0.70
-0.76%
After Hours: 91.32 0 0.00% 16:56 03/27 EDT
OPEN
88.86
PREV CLOSE
92.02
HIGH
93.42
LOW
88.54
VOLUME
602.25K
TURNOVER
--
52 WEEK HIGH
121.11
52 WEEK LOW
74.31
MARKET CAP
4.01B
P/E (TTM)
-37.3237
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of UTHR and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 11 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average UTHR stock price target is 132.44 with a high estimate of 243.00 and a low estimate of 85.00.

EPS

UTHR News

More
  • Hedge Funds Have Never Been This Bullish On United Therapeutics Corporation (UTHR)
  • Insider Monkey · 1d ago
  • United Therapeutics (UTHR) Down 8.7% Since Last Earnings Report: Can It Rebound?
  • Zacks · 1d ago
  • The Top 10 Biotechnology Companies
  • Investopedia · 2d ago
  • Arena Pharmaceuticals: Buy The Dip Ahead Of Catalyst-Rich 2020 And 2021
  • Seeking Alpha - Article · 03/18 21:40

Industry

Biotechnology & Medical Research
-2.43%
Pharmaceuticals & Medical Research
-0.87%

Hot Stocks

Symbol
Price
%Change

About UTHR

United Therapeutics Corporation is a biotechnology company. The Company is focused on the development and commercialization of products for the treatment of chronic and life-threatening conditions. The Company markets and sells four commercial therapies in the United States to treat pulmonary arterial hypertension (PAH): Remodulin (treprostinil) Injection; Tyvaso (treprostinil) Inhalation Solution (Tyvaso); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). The Company markets and sells an oncology product in the United States, Unituxin (dinutuximab) Injection (Unituxin), which is approved for treatment of neuroblastoma. The Company is also engaged in early-stage research and development of a number of organ transplantation-related technologies.
More

Webull offers kinds of United Therapeutics Corporation stock information, including NASDAQ:UTHR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, UTHR stock news, and many more online research tools to help you make informed decisions.